Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Manera** (also referred to as **MAnera** or **MEnera**) is an over-the-counter (OTC) formulation developed by **Medicinal Technologies** for reproductive health and fertility support. While the female-focused formulation (**MEnera**) is marketed for menstrual irregularities, menopausal symptoms, polycystic ovary syndrome (PCOS), and female infertility, the male-focused pipeline candidate (**MAnera** or **Manera**) is in preclinical development for male infertility, including low sperm count, poor sperm motility, and abnormal sperm morphology. The formulation is a combination of natural bioactive compounds, including allicin (an organosulfur compound derived from garlic), ubiquinol (the active antioxidant form of Coenzyme Q10), and *Lepidium meyenii* (maca) root extract, designed to act at the cellular and endocrine levels to restore hormonal rhythms and reduce oxidative stress.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Manera.